DANIELLE E. ZIMMERMAN MD
Prescription History 1750720595
Internal Medicine - Medical Oncology in Columbus, OH
Quality Rating: 67.02 out of 100 score
NPI Status: Active since June 14, 2013
Contact Information
410 W 10TH AVE
COLUMBUS, OH
ZIP 43210
Phone: (614) 293-5066
Fax: (614) 293-0047
Prescription History for Informed Healthcare Decisions
When choosing a healthcare provider, especially one who prescribes medications, having access to their prescribing history can be invaluable. This page offers detailed insights into the prescriptions DANIELLE E. ZIMMERMAN MD has written for Medicare beneficiaries in the past, empowering both current and prospective patients to make informed decisions about their healthcare.
Why This Information Matters
This Medicare Part D dataset provides transparency into the provider’s prescribing patterns, helping you understand the scope and nature of their pharmaceutical care. Here’s what you can learn:
- Prescribing Trends: See which medications—both generic and brand-name—this provider has most frequently prescribed.
- Specialization Insights: The types of drugs prescribed can give insight into the provider’s areas of focus or specialization, whether it’s managing chronic conditions, addressing acute illnesses, or providing preventive care.
- Cost Awareness: Learn about the total drug costs associated with these prescriptions, which may help you anticipate your own costs and coverage needs.
- Patient-Centered Decision Making: Understanding a provider’s prescribing practices helps you align their expertise with your health goals, ensuring the care you receive is consistent with your expectations.
- Generic Name
- Abiraterone Acetate
- Specialty
- Medical Oncology
- Times Prescribed
- 86
- Number of 30-Day Refills Prescribed
- 100
- What is this prescription?
- An androstene derivative that inhibits STEROID 17-ALPHA-HYDROXYLASE and is used as an ANTINEOPLASTIC AGENT in the treatment of metastatic castration-resistant PROSTATE CANCER.
- What is this prescription used for?
- This medication is used to treat prostate cancer. Abiraterone belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Abiraterone works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer. This medication should not be given to women or children.
- Generic Name
- Ondansetron Hcl
- Specialty
- Medical Oncology
- Times Prescribed
- 12
- Number of 30-Day Refills Prescribed
- 12
- What is this prescription used for?
- This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. It is also used to prevent and treat nausea and vomiting after surgery. It works by blocking one of the body's natural substances (serotonin) that causes vomiting.
- Generic Name
- Relugolix
- Specialty
- Medical Oncology
- Times Prescribed
- 16
- Number of 30-Day Refills Prescribed
- 16
- What is this prescription used for?
- Relugolix is used to treat prostate cancer in men. It is not a cure. Most types of prostate cancer need the male hormone testosterone to grow and spread. Relugolix works by reducing the amount of testosterone that the body makes. This helps slow or stop the growth of cancer cells.
- Generic Name
- Prednisone
- Specialty
- Medical Oncology
- Times Prescribed
- 109
- Number of 30-Day Refills Prescribed
- 122
- What is this prescription?
- A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
- What is this prescription used for?
- Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions.
This dataset provides information about prescriptions written for Medicare beneficiaries in the year 2022. It does not include prescriptions for patients with private insurance, Medicaid, or other coverage types. However, this information remains valuable for all patients, as it may reflect the provider's overall prescribing preferences and approach to pharmaceutical care. This can help you make better-informed decisions when considering or continuing care with this provider.